[go: up one dir, main page]

NO20020793L - Virkestoffkombinasjon med clonidin - Google Patents

Virkestoffkombinasjon med clonidin

Info

Publication number
NO20020793L
NO20020793L NO20020793A NO20020793A NO20020793L NO 20020793 L NO20020793 L NO 20020793L NO 20020793 A NO20020793 A NO 20020793A NO 20020793 A NO20020793 A NO 20020793A NO 20020793 L NO20020793 L NO 20020793L
Authority
NO
Norway
Prior art keywords
clonidine
active ingredient
ingredient combination
combination
pramipexole
Prior art date
Application number
NO20020793A
Other languages
English (en)
Other versions
NO20020793D0 (no
Inventor
Hans-Michael Brecht
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20020793D0 publication Critical patent/NO20020793D0/no
Publication of NO20020793L publication Critical patent/NO20020793L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Oppfinnelsen angår en kombinasjon aktive substanser. Denne kombinasjon består av clonidine og pramipexole for behandling av Restless Leg Syndrom.
NO20020793A 1999-08-19 2002-02-18 Virkestoffkombinasjon med clonidin NO20020793L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19938825A DE19938825A1 (de) 1999-08-19 1999-08-19 Wirkstoffkombination mit Clonidin
PCT/EP2000/007718 WO2001013902A2 (de) 1999-08-19 2000-08-09 Wirkstoffkombination enthaltend clonidin und pramipexol

Publications (2)

Publication Number Publication Date
NO20020793D0 NO20020793D0 (no) 2002-02-18
NO20020793L true NO20020793L (no) 2002-02-18

Family

ID=7918574

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020793A NO20020793L (no) 1999-08-19 2002-02-18 Virkestoffkombinasjon med clonidin

Country Status (19)

Country Link
US (1) US20020010201A1 (no)
EP (1) EP1210081A2 (no)
JP (1) JP2003507420A (no)
KR (1) KR20020060163A (no)
AR (1) AR025330A1 (no)
AU (1) AU6440600A (no)
BR (1) BR0013353A (no)
CA (1) CA2376606A1 (no)
CO (1) CO5200840A1 (no)
CZ (1) CZ2002515A3 (no)
DE (1) DE19938825A1 (no)
IL (1) IL147741A0 (no)
MX (1) MXPA02001138A (no)
NO (1) NO20020793L (no)
PE (1) PE20010642A1 (no)
PL (1) PL353358A1 (no)
TR (1) TR200200449T2 (no)
UY (1) UY26293A1 (no)
WO (1) WO2001013902A2 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
ATE480235T1 (de) 2001-12-11 2010-09-15 Univ Virginia Verwendung von pramipexol zur behandlung von amyotrophischer lateralsklerose
US20040048779A1 (en) * 2002-05-06 2004-03-11 Erwin Schollmayer Use of rotigotine for treating the restless leg syndrome
DE10220230A1 (de) * 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
CA2496920A1 (en) 2002-08-30 2004-03-11 Kyowa Hakko Kogyo Co., Ltd. Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders
PT1426049E (pt) * 2002-12-02 2005-09-30 Sanol Arznei Schwarz Gmbh Administracao iontoforetica de rotigotina para o tratamento da doenca de parkinson
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
CN102160865A (zh) 2006-05-16 2011-08-24 诺普神经科学股份有限公司 R(+)和s(-)普拉克索的组合物以及使用该组合物的方法
WO2008009664A2 (en) * 2006-07-19 2008-01-24 Boehringer Ingelheim International Gmbh Treatment of pain
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
JP2010521496A (ja) 2007-03-14 2010-06-24 ノップ ニューロサイエンシーズ、インク． キラル精製置換ベンゾチアゾールジアミンの合成
EP1987815A1 (en) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
EP2334185A4 (en) 2008-08-19 2011-09-21 Knopp Neurosciences Inc COMPOSITIONS AND METHODS FOR USE OF (R) -PRAMIPEXOL
US9512096B2 (en) 2011-12-22 2016-12-06 Knopp Biosciences, LLP Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
WO2014105783A1 (en) * 2012-12-28 2014-07-03 Noven Pharmaceuticals, Inc. Compositions and methods for transdermal delivery of amphetamine and clonidine
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
SMT202100119T1 (it) 2013-07-12 2021-05-07 Knopp Biosciences Llc Trattamento dei livelli elevati di eosinofili e/o basofili
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
ES2813674T3 (es) 2013-08-13 2021-03-24 Knopp Biosciences Llc Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b
EP3033081B1 (en) 2013-08-13 2021-05-12 Knopp Biosciences LLC Compositions and methods for treating chronic urticaria

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
DE4325491A1 (de) * 1993-07-29 1995-02-02 Boehringer Ingelheim Kg Verwendung von zentral wirksamen alpha-2-Agonisten zur Hemmung des Postaggressionsstoffwechsels
US6001861A (en) * 1998-01-16 1999-12-14 Pharmacia & Upjohn Company Use of pramipexole in the treatment of restless legs syndrome
DE19701619B4 (de) * 1997-01-17 2007-10-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Pramipexol zur Behandlung des restless legs syndroms
WO2000054773A1 (en) * 1999-03-12 2000-09-21 Nitromed, Inc. Dopamine agonists in combination with nitric oxide donors, compositions and methods of use

Also Published As

Publication number Publication date
PL353358A1 (en) 2003-11-17
IL147741A0 (en) 2002-08-14
JP2003507420A (ja) 2003-02-25
DE19938825A1 (de) 2001-04-26
BR0013353A (pt) 2002-04-23
KR20020060163A (ko) 2002-07-16
PE20010642A1 (es) 2001-06-08
MXPA02001138A (es) 2002-10-31
NO20020793D0 (no) 2002-02-18
EP1210081A2 (de) 2002-06-05
CA2376606A1 (en) 2001-03-01
CO5200840A1 (es) 2002-09-27
CZ2002515A3 (cs) 2002-05-15
TR200200449T2 (tr) 2002-08-21
AU6440600A (en) 2001-03-19
WO2001013902A3 (de) 2001-08-23
AR025330A1 (es) 2002-11-20
WO2001013902A2 (de) 2001-03-01
US20020010201A1 (en) 2002-01-24
UY26293A1 (es) 2001-04-30

Similar Documents

Publication Publication Date Title
NO20020793L (no) Virkestoffkombinasjon med clonidin
DE60109044D1 (de) Arzneimittel zur behandlung der mucositis, stomatitis und des behcetschen syndroms
HUP0303363A2 (hu) Kináz-inhibitor hatású heterociklusos vegyületek alkalmazása gyógyszerkészítmények előállítására
IL147643A0 (en) Drug therapy of the restless leg syndrome
MXPA00011422A (es) Derivados de bencimidazol como moduladores de ige.
ID30062A (id) Alanog-analog benzopiran tersubstitusi untuk pengobatan radang
DE60336664D1 (de) Nichtnukleosidische reverse-transkriptase-hemmer
NO20040726L (no) Kombinasjonspreparater av arylsubstituerte propanolaminderivater med andre aktive forbindelser og anvendelse derav.
MXPA05003253A (es) Nuevos derivados de pirimidinamida y el uso de los mismos.
ATE402176T1 (de) Pyrrolidin- und azetidinverbindungen alsccr5- antagonisten
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
ATE410426T1 (de) Heterocyclische verbindungen alsccr5-antagonisten
ATE295174T1 (de) Arzneimittel zur behandlung von bluthochdruck
DE60132851D1 (de) Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension
DE60026491D1 (de) Melagatran zur behandlung von entzündungen
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
ATE289196T1 (de) Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
HUP0001913A2 (hu) Pramipexole alkalmazása állandóan mozgó láb szindróma kezelésére szolgáló gyógyszerkészítmények előállítására
DE69937692D1 (de) Arzneimittel zur behandlung der hemicrania
AU3922900A (en) Use of (valeriana) for the treatment of restless leg syndrome and related disorders
DE50307521D1 (de) Arzneimittel zur behandlung des "systemic inflammatory response syndrome"
DE60043936D1 (de) Vorbeugung und behandlung von p. gingivalis infektion
DE50112512D1 (de) Phenanthridinderivate und phenanthridin enthaltende antitumorale arzneimittel
ES1043751Y (es) Tabla vibradora de efectos terapeuticos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application